āĻšā§āĻŽLAURUSLABS âĸ NSE
add
āϞāϰāĻžāϏ āϞā§āϝāĻžāĻŦāϏ
ā§ā§¯ā§¨.ā§Šā§Ģâš
ā§§ā§Ļ āĻā§āϞ, ā§Š:ā§Ģā§Ž:ā§Ēā§§ PM GMT +ā§Ģ:ā§Šā§Ļ · INR · NSE · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§ā§¯ā§Ē.ā§Ēā§Ļâš
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§ā§Žā§Š.ā§§ā§Ģâš - ā§Žā§Ļā§Ļ.ā§Ļā§Ļâš
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§Ēā§§ā§Ē.ā§Ļā§Ļâš - ā§Žā§Ļā§Ļ.ā§Ļā§Ļâš
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§Ē⧍ā§.ā§Ģ⧝āĻā§ INR
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
⧍⧧.ā§Žā§ŠÂ āϞāĻž
P/E āĻ
āύā§āĻĒāĻžāϤ
⧧⧧⧝.ā§Šā§¨
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
ā§Ļ.ā§§ā§Ģ%
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
NSE
āĻāĻŦāϰ⧠āϰā§ā§āĻā§
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(INR) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§§ā§.⧍ā§ĻāĻļāĻ¤Â āĻā§ | ⧧⧝.ā§Ē⧝% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Ģā§§ā§Ŧ.ā§ā§¨Â āĻā§ | ā§Ž.ā§Šā§Ģ% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§¨ā§Šā§Š.ā§Ŧā§Â āĻā§ | ⧍ā§Ļ⧝.ā§Ļā§Ģ% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ā§§ā§Š.ā§Ģā§Ž | ā§§ā§Ģā§Ž.ā§Ŧā§% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | ā§Ē.ā§Šā§Š | ⧍ā§Ļ⧝.⧍⧝% |
EBITDA | ā§Ē⧧⧍.ā§Ēā§¨Â āĻā§ | ā§Žā§Š.ā§Ļā§Ļ% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ⧍ā§Ģ.⧍⧧% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(INR) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§§ā§Ēā§Ē.ā§¨ā§§Â āĻā§ | ā§§.ā§Žā§§% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§¯ā§Š.ā§Šā§ŦāĻļāĻ¤Â āĻā§ | ā§§ā§§.ā§Šā§§% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Ēā§.ā§Šā§ŠāĻļāĻ¤Â āĻā§ | ā§§ā§Ļ.ā§Žā§§% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Ēā§Ŧ.ā§Ļā§ŠāĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§Ģā§Š.ā§¯ā§ŠÂ āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ⧝.ā§Ģā§Ž | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | â | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§§ā§Ļ.ā§Žā§Ģ% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(INR) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§¨ā§Šā§Š.ā§Ŧā§Â āĻā§ | ⧍ā§Ļ⧝.ā§Ļā§Ģ% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | â | â |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | â | â |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | â | â |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | â | â |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| â | â |
āϏāĻŽā§āĻĒāϰā§āĻā§
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
⧍ā§Ļā§Ļā§Ģ
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§Ŧ,ā§§ā§Ŧā§